Celltrion’s Remsima SC Will No Longer Need IV Loading

EMA Committee Endorses Direct Subcutaneous Use Of Infliximab Biosimilar

 
• By David Wallace
  
No Loading Sign Brick Wall
No intravenous loading will be required ahead of subcutaneous administration • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products